LG-62 DEVELOPING RISK-BASED SELECTION CRITERIA FOR THE NEXT SIOP TRIAL OF “SIGHT-SAVING THERAPY” FOR CHILDREN WITH NF1-ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG) - A CASE-BASED CONSENSUS SURVEY

Gelijkaardige items

• LG-61 DEVELOPING RISK-BASED SELECTION CRITERIA FOR THE NEXT SIOP TRIAL OF “SIGHT-SAVING THERAPY” FOR CHILDREN WITH NF1-ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG) - A MULTI-DISCIPLINARY CONSENSUS WORKSHOP
  door: Walker, David, et al.
  Gepubliceerd in: (2016)
• OP23 A CONSENSUS WORKSHOP TO DEVELOP RISK-BASED SELECTION CRITERIA FOR THE NEXT SIOP TRIAL OF “SIGHT-SAVING THERAPY” FOR CHILDREN WITH NF1-ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG)
  door: Opocher, Enrico, et al.
  Gepubliceerd in: (2015)
• TRTH-22. DEVELOPING RISK-BASED SELECTION CRITERIA FOR THE NEXT SIOP TRIAL OF “SIGHT-SAVING THERAPY” FOR CHILDREN WITH NF1-ASSOCIATED VISUAL PATHWAY GLIOMA (NF1-VPG) – A QUALITATIVE ANALYSIS OF A CONSENSUS SURVEY
  door: Walker, David, et al.
  Gepubliceerd in: (2017)
• NFM-04. INITIAL MANAGEMENT STRATEGY AS A DISCRIMINATOR OF VISUAL OUTCOME IN CHILDREN PRESENTING WITH NEUROFIBROMATOSIS TYPE 1 AND OPTIC PATHWAY GLIOMA - RESULTS FROM A SOCIÉTÉ INTERNATIONALE D’ONCOLOGIE PÉDIATRIQUE EUROPE (SIOPE) CLINICAL TRIALS WORKSHOP
  door: Azizi, Amedeo A, et al.
  Gepubliceerd in: (2018)
• NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat
  door: Azizi, Amedeo A, et al.
  Gepubliceerd in: (2020)